{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:08:30Z","timestamp":1785798510576,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":6914,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1038\/ki.1997.39","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T15:15:29Z","timestamp":1178637329000},"page":"317-323","source":"Crossref","is-referenced-by-count":97,"title":["Effective suppression of parathyroid hormone by 1\u03b1-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism"],"prefix":"10.1016","volume":"51","author":[{"suffix":"Jr.","given":"Alexander U.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Mazess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene M.","family":"Kyllo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce C.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack W.","family":"Coburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1997.39_bb0010","series-title":"Current Nephrology","first-page":"133","article-title":"Divalent ion metabolism","author":"Jara","year":"1996"},{"key":"10.1038\/ki.1997.39_bb0015","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1038\/ki.1997.39_bb0020","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1210\/endo-119-6-2864","article-title":"Suppression by 1,25(OH)2D3 of transcription of the parathyroid hormone gene","volume":"119","author":"Russell","year":"1986","journal-title":"Endocrinol"},{"key":"10.1038\/ki.1997.39_bb0025","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","article-title":"The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion","volume":"84","author":"Brown","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1997.39_bb0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.1997.39_bb0035","first-page":"1204","article-title":"Effect of hexafluorocalcitriol on renal osteodystrophy in hemodialysed patients","volume":"11","author":"Morii","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1997.39_bb0040","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jn\/114.11.2043","article-title":"Antirachitic activity of 1\u03b1-hydroxyergocalciferol and 1\u03b1-hydroxycholecalciferol in rats","volume":"114","author":"Sj\u00f6den","year":"1984","journal-title":"J Nutr"},{"key":"10.1038\/ki.1997.39_bb0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3181\/00379727-178-42028","article-title":"1\u03b1-hydroxyvitamin D2 is less toxic than 1\u03b1-hydroxyvitamin D3 in the rat","volume":"178","author":"Sj\u00f6den","year":"1985","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1038\/ki.1997.39_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02576679","article-title":"Effects of vitamin D2 analogs on calcium metabolism in vitamin D-deficient rats and in MC3T3 osteoblastic cells","volume":"191","author":"Sato","year":"1991","journal-title":"Res Exp Med"},{"key":"10.1038\/ki.1997.39_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jbmr.5650090504","article-title":"Effects of increasing doses of 1\u03b1-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women","volume":"9","author":"Gallagher","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.1997.39_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014An evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.39_bb0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jcem-73-3-516","article-title":"Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients","volume":"73","author":"Solal","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.1997.39_bb0070","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocnnol Metab"},{"key":"10.1038\/ki.1997.39_bb0075","series-title":"Use of the PTH (IRMA) Assay in Patients with Impaired Renal Function and Renal Osteodystrophy","first-page":"1","author":"Segre","year":"1990"},{"key":"10.1038\/ki.1997.39_bb0080","series-title":"Primer of Biostatistics","author":"Glantz","year":"1987"},{"key":"10.1038\/ki.1997.39_bb0085","first-page":"216","article-title":"Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism","volume":"40","author":"Fischer","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.1997.39_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000187887","article-title":"Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: A randomized prospective trial","volume":"67","author":"Herrmann","year":"1994","journal-title":"Nephron"},{"key":"10.1038\/ki.1997.39_bb0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1997.39_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000186210","article-title":"The \u2018oral 1,25-dihydroxyvitamin D3 pulse therapy\u2019 in hemodialysis patients with severe secondary hyperparathroidism","volume":"57","author":"Tsukamoto","year":"1991","journal-title":"Nephron"},{"key":"10.1038\/ki.1997.39_bb0105","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ki.1994.375","article-title":"Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol","volume":"46","author":"Cannella","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.39_bb0110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","article-title":"The effect of long-term calcitriol administration on parathyroid function in hemodialysis patients","volume":"2","author":"Rodriguez","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.1997.39_bb0115","first-page":"822","article-title":"Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism","volume":"7","author":"Malberti","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1997.39_bb0120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0272-6386(95)90454-9","article-title":"The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism","volume":"26","author":"Llach","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.1997.39_bb0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.V73488","article-title":"Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients","volume":"7","author":"Levine","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.1997.39_bb0130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.39_bb0135","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(12)80831-6","article-title":"Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol","volume":"19","author":"Sprague","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.1997.39_bb0140","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.39_bb0145","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1681\/ASN.V34995","article-title":"The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic dialysis patients","volume":"3","author":"Oettinger","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.1997.39_bb0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ki.1993.83","article-title":"Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism","volume":"43","author":"Finch","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.39_bb0155","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000188742","article-title":"Calcitriol pulse therapy for severe hyperparathyroidism or calcium salts as phosphate binders in renal dialysis patients","volume":"71","author":"Gonella","year":"1995","journal-title":"Nephron"},{"key":"10.1038\/ki.1997.39_bb0160","first-page":"324","article-title":"Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism","volume":"43","author":"Dressler","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.1997.39_bb0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000185744","article-title":"Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis","volume":"53","author":"Brandi","year":"1989","journal-title":"Nephron"},{"key":"10.1038\/ki.1997.39_bb0170","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000186004","article-title":"Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis","volume":"55","author":"Ljunghall","year":"1990","journal-title":"Nephron"},{"issue":"Suppl 41","key":"10.1038\/ki.1997.39_bb0175","first-page":"S121","article-title":"Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1\u03b1(OH) vitamin D3, oral CaCO3 and low dialysate calcium","volume":"43","author":"Moriniere","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1997.39_bb0180","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815598724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815598724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T23:57:23Z","timestamp":1635551843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815598724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["S0085253815598724"],"URL":"https:\/\/doi.org\/10.1038\/ki.1997.39","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}